Targovax ASA: New member of the board of directors
Oslo, Norway, 30 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the extraordinary general meeting of Targovax ASA has today appointed Patrick Vink as the new chairman of the board of directors. The previous chairman of the board, Jónas Einarsson, replaces Lars Lund-Roland as an ordinary member of the board of directors. The board of directors of Targovax ASA will now have the following members: · Patrick Vink (chairman); · Jónas Einarsson; · Bente-Lill Romøren; ·